Emmis Acquisition (EMIS) vs Oramed Pharmaceuticals (ORMP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Oramed Pharmaceuticals is the larger company by market cap ($174.7 million vs $162.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMIS | ORMP |
|---|---|---|
| Share price | $10.27 | $4.20 |
| Market cap | $162.02M | $174.71M |
| 1-day change | 0.00% | -3.89% |
| YTD return | +3.22% | +47.37% |
| 1-year return | — | +75.73% |
| 5-year return | — | -80.96% |
| P/E ratio (TTM) | — | 1.02 |
| EPS (TTM) | — | $4.13 |
| Dividend yield | 0.00% | 5.92% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.27 | $5.47 |
| 52-week low | $9.90 | $2.09 |
| Distance from 52-week high | 0.00% | -23.22% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +66.67% |
| Average volume | 13.67K | 190.50K |
| Shares outstanding | 11.94M | 41.60M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Oramed Pharmaceuticals offers a meaningfully higher dividend yield (5.92% vs 0.00%).
About Emmis Acquisition
EMIS stock →Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Health Care · Biotechnology: Pharmaceutical Preparations
About Oramed Pharmaceuticals
ORMP stock →Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
Health Care · Biotechnology: Pharmaceutical Preparations
EMIS vs ORMP FAQ
Which is bigger, Emmis Acquisition or Oramed Pharmaceuticals?
Oramed Pharmaceuticals (ORMP) is larger, with a market capitalization of $174.71M compared with $162.02M for Emmis Acquisition (EMIS).
Which pays a higher dividend, Emmis Acquisition or Oramed Pharmaceuticals?
Oramed Pharmaceuticals pays a dividend yielding 5.92%, while Emmis Acquisition does not currently pay a regular dividend.
Are Emmis Acquisition and Oramed Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.